News
News

Dr. Jan van de Winkel Joins Hookipa as Chairman of its Board of Directors

in portfolio news

Hookipa Biotech AG (“Hookipa”), a company pioneering an innovative class of immunotherapies for oncology and infectious diseases, today announced the appointment of Dr. Jan van de Winkel as Chairman of its Board of Directors.
Dr. Jan van de Winkel is currently President and Chief Executive Officer of Genmab A/S. He is widely recognized as one of the most successful biotech entrepreneurs in the world, with a blend of outstanding scientific and managerial expertise. He has built Genmab from ’bench to bedside’ with commercial stage immunotherapy products.

Subscribe